Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
- 10 December 2022
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 242, 108330
Abstract
No abstract availableKeywords
Funding Information
- Fonds de Recherche du Québec Santé
This publication has 91 references indexed in Scilit:
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trialThe Lancet Diabetes & Endocrinology, 2014
- Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemiaAmerican Journal of Physiology-Renal Physiology, 2014
- The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitusBritish Journal of Clinical Pharmacology, 2013
- Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor, in subjects with renal impairmentDiabetes, Obesity and Metabolism, 2013
- Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes MellitusThe Journal of Clinical Pharmacology, 2013
- Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy SubjectsClinical Pharmacology in Drug Development, 2013
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and HumansDrug Metabolism and Disposition, 2010
- Adenosine A1 Receptors Determine Glomerular Hyperfiltration and the Salt Paradox in Early Streptozotocin Diabetes MellitusNephron Physiology, 2009
- THE EXCRETION OF INULIN, XYLOSE AND UREA BY NORMAL AND PHLORIZINIZED MAN 1Journal of Clinical Investigation, 1935